Shares of Celcuity Inc (CELC) are experiencing a significant uptick in Friday's trading session, soaring 5.19% as investors react to recent analyst commentary. The healthcare company's stock movement comes on the heels of analysts weighing in on the company, suggesting a positive outlook that has excited market participants.

The surge in Celcuity's stock price underscores the impact that analyst opinions can have on investor sentiment, particularly in the healthcare sector where research and development progress are closely watched. While specific details of the analysts' insights were not immediately available, the market's reaction indicates that the commentary was favorably received.

This latest development for Celcuity comes amid broader interest in the healthcare sector, with analysts also providing insights on other companies such as Pelthos Therapeutics. As the trading day progresses, investors will be keen to see if Celcuity can maintain its momentum and if any further details emerge regarding the analyst reports that have sparked this notable intraday rally.